ArticleEuropean heart journal open2026
Predicting common cardiovascular and non-cardiovascular outcomes after new-onset atrial fibrillation: an analysis from a UK nationwide primary-secondary care linkage dataset.
Article in European heart journal open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aims: Atrial fibrillation (AF) increases the risk of major cardiovascular and neurological complications. Utilization of risk schemes for identifying patients at risk for stroke has improved outcomes for patients with AF. Objectives: Using linked UK primary and secondary care data, we identified risk predictors and develop risk models for heart failure (HF) hospitalization, myocardial infarction (MI) hospitalization, vascular dementia, sepsis, sudden cardiac death (SCD), and all-cause death in the AF population. Methods and results: We included 198 995 patients diagnosed with AF between January 1998 and May 2016. We developed multivariable Cox regression models to predict outcome incidence after AF diagnosis, using 70% of the data for derivation and 30% for validation. Model performance was assessed using Harrell's c-index. Predictor variables were selected based on their availability in routine clinical practice. Among the assessed predictors, excessive alcohol intake, HF, MI, sepsis, and stroke showed the strongest associations with adverse outcomes. The prediction models demonstrated fair to moderate discrimination, with c-index values of 0.70 (95% CI 0.70-0.71) for HF hospitalization, 0.64 (95% CI 0.63-0.65) for MI hospitalization, 0.76 (95% CI 0.75-0.77) for vascular dementia, 0.66 (95% CI 0.65-0.67) for sepsis, 0.65 (95% CI 0.62-0.68) for SCD, and 0.71 (95% CI 0.71-0.71) for all-cause death. Conclusion: In patients with AF, we developed prediction models that demonstrate fair to good performance. Our models, based on variables easily obtainable in routine clinical care, may facilitate patient risk stratification and guide further diagnostic or preventive interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.